Navigation Links
Ukraine's First Lady Kateryna Yushchenko Receives Inaugural MaxWell International Public Health Award
Date:6/24/2008

- Chair of 'Ukraine 3000 International Charitable Foundation' honored for

her work to improve healthcare for Ukrainian children, women -

WASHINGTON, June 24 /PRNewswire/ -- Ukraine's "First Lady," American-born Kateryna Yushchenko has been awarded the first-ever MaxWell International Public Health Award for 2008.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080624/NETU078LOGO )

The award is presented by MaxWell Biocorporation to an international public figure or organization that has made outstanding contributions to improving the health of under-served populations and demonstrated decisive leadership on public health issues.

Mrs. Yushchenko was chosen as the first recipient of the award in recognition of her service as Chair of the Ukraine 3000 International Charitable Foundation, her efforts on behalf of Ukraine's children, and her leadership in promoting early detection and treatment of breast cancer among Ukrainian women.

"Improved medical care in Ukraine is a priority for my husband, President Victor Yushchenko, and for my Foundation 'Ukraine 3000.' The health care sector in Ukraine is undergoing major change and improvement, but still needs much reform, investment, and training to bring it up to European standards," Mrs. Yushchenko wrote in a May 18 letter to Dr. Alibek.

"We appreciate MaxWell Biocorporation's investments into the Ukrainian health care sector and its efforts to provide Ukrainians with affordable, high quality pharmaceutical products and medical services," she added.

Dr. Ken Alibek, founder, President and CEO of MaxWell Biocorporation, presented the award to Mrs. Yushchenko during the opening of the MaxWell USA symposium "21st Century Pharmaceutical Production and Health Care Research & Delivery in the CIS." The symposium was held at the Ritz-Carlton in Washington, D.C. on May 28 (http://www.max-well.com/eng/press_whale.php).

Ukrainian Ambassador to the United States Oleh Shamshur received the award on behalf of Mrs. Yushchenko (http://www.max-well.com/img/photogallery/picture032_1.jpg).

About MaxWell

MaxWell Biocorporation is a U.S.-based, privately-held international medical and pharmaceutical company with wholly owned subsidiaries and affiliates in the United States and Ukraine dedicated to increasing life expectancy and improving the quality of life of people in Ukraine and other underserved emerging healthcare markets in the former Soviet Union. MaxWell targets oncological, cardiological, chronic infectious and autoimmune disorders and diseases through the development, production, and introduction into clinical practice of sophisticated, high quality, and affordable off-patent generic biopharmaceutical and chemopharmaceutical medicines and the latest diagnostic and therapeutic methods. MaxWell = "Maximum Wellness."

"We Help You Live Longer"

Contact:

Alex Meerovich

A.Meerovich@max-well.com

202-454-3403


'/>"/>
SOURCE MaxWell Biocorporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. First biomarker discovered that predicts prostate cancer outcome
2. FDA Approves First Anti-Psychotic for Kids
3. Single-incision belly-button surgery to remove kidney performed first at UT Southwestern
4. First study examines newly-licensed RN work attitudes and intentions
5. Glades General Hospital First in Palm Beach County to Provide On-Site Electronic Birth Registration
6. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
7. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
8. High and mighty: first common height gene identified by researchers behind obesity gene finding
9. APA Comments on FDAs First Approval of Medication to Treat Pediatric Schizophrenia and Bipolar Disorder
10. TriWest Creates First-of-its-Kind Partnership to Offer Military Leaders With Grief Support Program
11. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... Somnoware, a leading ... Word(TM) Online(TM), which enables sleep physicians to create and edit their interpretation reports. ... and provides a familiar interface that does not require additional training to use. ...
(Date:4/28/2017)... Grants Pass, OR (PRWEB) , ... April 28, ... ... Adetutu Ijose, http://www.foodsthathealdaily.com , http://www.wiredlifesolutions.com , “Computers are everywhere and ... Kleyne Hour Power of Water, Global Climate Change and Your Health on Voice ...
(Date:4/28/2017)... ... April 28, 2017 , ... The Texas Cord Blood ... to the labor and delivery team at Women’s Hospital at Renaissance in Edinburg for ... birth at the hospital and decide to donate. , “Women’s Hospital at Renaissance ...
(Date:4/28/2017)... ... ... Pastor and Overseer at The House of Yahweh in Abilene, Texas, has published a new ... not. Yisrayl says with so many titles and names for the Creator, it’s hard ... a little Scripture, backed with a lot of research, the truth is undeniable. , ...
(Date:4/28/2017)... , ... April 28, 2017 , ... NuevaCare, a leading ... diverse as Millbrae, Burlingame, and Palo Alto, is proud to announce information upgrades to ... to bookmark and read organized content on topics such as home care (generally) as ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... --  ZappRx, Inc ., a digital health company focused on ... it closed $25 million in Series B funding led by ... Seattle that is part of a ... B round included participation from SR One , who ... (formerly Google Ventures). As part of the financing, ...
(Date:4/20/2017)... , April 20, 2017 Eyevensys, ... the first non-viral gene expression technology that enables the ... eye to address a wide range of ophthalmic diseases, ... and Healthcare products Regulatory Agency (MHRA) to advance its ... ...
Breaking Medicine Technology: